Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Goodwill & Intangibles (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Goodwill & Intangibles over the past 15 years, most recently at $18.1 million for Q2 2025.

  • For Q2 2025, Goodwill & Intangibles changed 0.0% year-over-year to $18.1 million; the TTM value through May 2025 reached $18.1 million, changed 0.0%, while the annual FY2025 figure was $18.1 million, 0.0% changed from the prior year.
  • Goodwill & Intangibles for Q2 2025 was $18.1 million at Lifecore Biomedical, Inc. \De\, roughly flat from $18.1 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $18.1 million in Q2 2022 and troughed at $18.1 million in Q1 2021.
  • A 5-year average of $18.1 million and a median of $18.1 million in 2021 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: plummeted 80.14% in 2021 and later grew 0.11% in 2022.
  • Year by year, Goodwill & Intangibles stood at $18.1 million in 2021, then changed by 0.0% to $18.1 million in 2022, then changed by 0.0% to $18.1 million in 2023, then changed by 0.0% to $18.1 million in 2024, then changed by 0.0% to $18.1 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for LFCR at $18.1 million in Q2 2025, $18.1 million in Q1 2025, and $18.1 million in Q4 2024.